Long-term Efficacy of Perampanel in a Child with Dravet Syndrome

Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) mostly due to mutations in SCN1A gene. Perampanel is a selective and non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist. There is increasing experience in the use of perampa...

Descripción completa

Detalles Bibliográficos
Autores principales: Turón-Viñas, Eulàlia, Díaz-Gómez, Asunción, Coca, Elisabet, Dougherty, Lucía, Ruiz, Carlos, Boronat, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532213/
https://www.ncbi.nlm.nih.gov/pubmed/34692895
http://dx.doi.org/10.1177/2329048X211050711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532213/
https://www.ncbi.nlm.nih.gov/pubmed/34692895
http://dx.doi.org/10.1177/2329048X211050711

Ejemplares similares